CTI BioPharma reports third quarter 2014 financial results
CTI BioPharma reported net income of $4.6 million, or $0.03 per share in the 2014 third quarter versus a net loss of $22.4 million, or ($0.20) per share, for the same 2013 period. Total revenues for the 2014 third quarter were $39.5 million versus $364,000 in the same prior year period. October 29, 2014